Black Country Pathology Services has seen its "biggest go-live to date" with the Clinisys laboratory information system that is being rolled-out to all of its laboratories.
The Dudley lab had a successful “big bang” go-live with WinPath Enterprise at the end of September and went-live with the Clinisys Integrated Clinical Environment, or ICE, at the same time.
Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane, Bayer’s novel macrocyclic gadolinium-based compound currently in Phase II development, at the Radiological Society of North America (RSNA) Annual Meeting. 
NHS patients throughout the West Midlands are to benefit from a digital pathology programme, designed to help reduce cancer backlogs, transform services, and improve the speed and accuracy of cancer diagnosis.
As one of the largest digital pathology programmes in Europe, the West Midlands Cancer Alliance initiative covers a population of 5.8 million people across four NHS pathology networks and 17 NHS trusts.
Digital speech biomarker company ki:elements has published validation results on the use of its ki:e speech biomarker for cognition (SB-C) in early Alzheimer’s disease in the "Karger - Digital Biomarkers" journal.(1)
Two European dementia studies - the Dutch DeepSpA study in collaboration with Maastricht University & the Scottish SPeAK study in collaboration with University of Edinburgh - helped to validate the psychometric properties of the SB-C.
Cleveland Clinic and IBM have begun deployment of the first private sector onsite, IBM-managed quantum computer in the United States. The IBM Quantum System is to be located on Cleveland Clinic’s main campus in Cleveland.
The first quantum computer in healthcare, anticipated to be completed in early 2023, is a key part of the two organizations'10-year partnership aimed at fundamentally advancing the pace of biomedical research through high-performance computing.
UK headquartered healthcare analytics company C2-Ai has appointed a senior clinician as its new medical director international.
Dr Mike Roberts, who has a background in emergency medicine and cardiothoracic surgery, has worked in both the NHS and in New Zealand, where he has held chief medical officer and medical director roles for more than 15 years.